Wolfe Research analyst Justin Lake downgraded HCA Healthcare (HCA) to Peer Perform from Outperform without a price target The firm cites the potential for healthcare exchange pressure in 2026 and provider tax pressure in 2028 and beyond for the downgrade. Wolfe now sees a less compelling risk/reward for the shares amid HCA’s legislative pressure.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HCA:
- HCA Healthcare price target lowered to $390 from $416 at Barclays
- Hold Rating for HCA Healthcare Amid Strong Q2 Results and Future Headwinds Concerns
- HCA Healthcare Reports Strong Q2 2025 Results
- HCA Healthcare: Mixed Financial Performance and Volume Growth Concerns Lead to Hold Rating
- Morning Movers: Intel lower following second quarter earnings